Dr. Larisa J. Geskin, MD

Dr. Geskin practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Geskin's NPI, 1063485050, was assigned on February 9, 2006. Dr. Geskin graduated from University of Pittsburgh School of Medicine in 1998. Dr. Geskin holds New York license 272145-1.

Dr. Geskin's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Geskin's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Geskin is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Geskin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geskin practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Geskin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Geskin is licensed in New York.

CMS data shows 1,941 Medicare services from Dr. Geskin across 19 procedure codes in 2024, for 556 Medicare patients. Medicare paid $229,257 for them. Every service was in an office.

CMS counts 556 Medicare patients who saw Dr. Geskin in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Geskin's median patient age at 63, with 53% women.

In 2024, Dr. Geskin wrote 2,015 Medicare Part D claims for 488 patients. 82% of them were for generic drugs. CMS names the drug for 1,812 of them, across 37 drugs with 11 or more claims each, at $1,671,591 in total drug cost. In 2023, CMS named 1,443 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Geskin for performance year 2024, reported through an alternative payment model (APM). Dr. Geskin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Geskin as offering telehealth. CMS counts 474 procedures of removal of skin lesions by Dr. Geskin, more than 86% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Geskin, published from 2015 to 2025. 2025 was the busiest year, with 8. The most frequent topics are Skin Neoplasms, Mycosis Fungoides and Biomarkers, Tumor. Dr. Geskin has published most often in JAAD Case Rep. Dr. Geskin's most frequent co-authors are Oleg E. Akilov, MD, PhD, Madeleine Duvic, MD and Alejandro A. Gru, MD.

CMS Open Payments shows 231 general payments to Dr. Geskin from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Helsinn Healthcare SA paid the most, $126,298. It also lists 1 research payment totaling $1,338 in 2017.

Dr. Geskin graduated from University of Pittsburgh School of Medicine in 1998.